RecruitingNCT07563296
About this title
KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury
Read the official source — NCT07563296Official study titleKALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury
In Salt Lake CityPTSDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Irma Fleming
RecruitingNCT06872463
About this title
Karolinska Schizophrenia Project
Read the official source — NCT06872463Official study titleBrain Immunoactivation in Drug-Naive Patients with First Episode Schizophrenia
In StockholmSchizophreniaObservational studyAges 18+
- Countries
- Sweden
- Sponsor
- Karolinska Institutet
RecruitingNCT05696691
About this title
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
Read the official source — NCT05696691Official study titleA Randomized Pilot Trial of Intramuscular Ketamine and Crisis Response Planning for Suicide Prevention in the Emergency Department
In San AntonioSuicidalityMedication studyAges 18–70
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center at San Antonio
RecruitingNCT02122562
About this title
Ketamine Alcohol (in Treatment-Resistant Depression)
Read the official source — NCT02122562Official study titleFunctional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup
In Iowa CityDepressionMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Mark Niciu
RecruitingACTRN12623000817640
Official study titleKetamine versus Ketamine plus Behavioural Activation Therapy for Adults with Treatment Resistant Depression
In New ZealandDepressionInterventional studyAges 18–65
- Countries
- New Zealand
- Sponsor
- University of Otago
RecruitingACTRN12619000311156
Official study titleKetamine Therapy For Internalizing Disorders: Is There A Single Mechanism?
In New ZealandPTSD, OCD, ...Interventional studyAges 18–45
- Countries
- New Zealand
- Sponsor
- University of Otago
RecruitingNCT06969937
About this title
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
Read the official source — NCT06969937Official study titlePhase II, Randomised, Placebo-controlled, Double Blind, Parallel Group, Single Centre Study Investigating Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
In ZurichAddictionMedication studyAges 18–65
- Countries
- Switzerland
- Sponsor
- Dr. med. Marcus Herdener
RecruitingNCT06125054
About this title
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Read the official source — NCT06125054Official study titleBoosting and Guiding Neuroplasticity by Combining Ketamine with Neurofeedback-assisted Learning - Towards an Individualized and Integrated Pharmaco-psychotherapy for Cocaine Addiction
In ZurichAddictionMedication studyAges 18–55
- Countries
- Switzerland
- Sponsor
- Dr. med. Marcus Herdener
RecruitingNCT04892251
About this title
Ketamine Assisted Psychotherapy for Opioid Use Disorder
Read the official source — NCT04892251Official study titleKetamine Assisted Psychotherapy for Opioid Use Disorder
In Salt Lake CityAddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of Utah
RecruitingNCT07009158
About this title
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Read the official source — NCT07009158Official study titleKetamine Assisted Psychotherapy to Improve Quality of Life in Veterans and Civilians With Comorbid Chronic Pain and Posttraumatic Stress Disorder: an Open-label Randomized Controlled Trial.
In KingstonPTSDMedication studyAges 18–64
- Countries
- Canada
- Sponsor
- Dr. Yuliya Knyahnytska
RecruitingNCT07088380
About this title
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Read the official source — NCT07088380Official study titleThe Additive Effect of Ketamine in Combination With ElectroConvulsive Stimulation (ECS) in Major Depressive Disorder (MDD): a Translational Study
In MilanDepressionMedication studyAges 18–70
- Countries
- Italy
- Sponsor
- Università Vita-Salute San Raffaele